MA51126A - Dérivés de 2-oxo-1-pyrrolidinyl imidazothiadiazole - Google Patents

Dérivés de 2-oxo-1-pyrrolidinyl imidazothiadiazole

Info

Publication number
MA51126A
MA51126A MA051126A MA51126A MA51126A MA 51126 A MA51126 A MA 51126A MA 051126 A MA051126 A MA 051126A MA 51126 A MA51126 A MA 51126A MA 51126 A MA51126 A MA 51126A
Authority
MA
Morocco
Prior art keywords
oxo
imidazothiadiazole derivatives
pyrrolidinyl
pyrrolidinyl imidazothiadiazole
derivatives
Prior art date
Application number
MA051126A
Other languages
English (en)
Inventor
Hugues Chanteux
Laurent Provins
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of MA51126A publication Critical patent/MA51126A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA051126A 2017-12-12 2018-12-04 Dérivés de 2-oxo-1-pyrrolidinyl imidazothiadiazole MA51126A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17206684 2017-12-12

Publications (1)

Publication Number Publication Date
MA51126A true MA51126A (fr) 2020-10-21

Family

ID=60673169

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051126A MA51126A (fr) 2017-12-12 2018-12-04 Dérivés de 2-oxo-1-pyrrolidinyl imidazothiadiazole

Country Status (10)

Country Link
US (1) US11155566B2 (fr)
EP (1) EP3724198B1 (fr)
JP (1) JP7126547B2 (fr)
CN (1) CN111465607A (fr)
BR (1) BR112020009880A2 (fr)
CA (1) CA3083166A1 (fr)
EA (1) EA202091403A1 (fr)
ES (1) ES2912612T3 (fr)
MA (1) MA51126A (fr)
WO (1) WO2019115292A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2947618T3 (es) * 2018-05-08 2023-08-14 UCB Biopharma SRL Derivados de 1-imidazotiadiazolo-2H-pirrol-5-ona

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008542323A (ja) * 2005-06-01 2008-11-27 ユセベ ファルマ ソシエテ アノニム 2−オキソ−1−ピロリジン誘導体、その製造方法及びその使用
NZ566240A (en) 2005-09-15 2011-05-27 Ucb Pharma Sa 4-substituted pyrrolidin-2-ones and their use
RS54595B1 (sr) 2009-10-23 2016-08-31 Ucb Biopharma Sprl. Derivati 2-okso-1-pirolidinil imidazotiadiazola
HRP20151419T1 (hr) * 2011-04-18 2016-01-29 Ucb Biopharma Sprl Derivati 2-okso-1-imidazolidinil imidazotiadiazola
WO2012143116A1 (fr) * 2011-04-18 2012-10-26 Ucb Pharma, S.A. Dérivés de 4-oxo-1-imidazolidinyl imidazothiadiazole

Also Published As

Publication number Publication date
EP3724198A1 (fr) 2020-10-21
ES2912612T3 (es) 2022-05-26
BR112020009880A2 (pt) 2020-11-03
CA3083166A1 (fr) 2019-06-20
WO2019115292A1 (fr) 2019-06-20
CN111465607A (zh) 2020-07-28
JP7126547B2 (ja) 2022-08-26
US20200399288A1 (en) 2020-12-24
US11155566B2 (en) 2021-10-26
EA202091403A1 (ru) 2020-10-14
EP3724198B1 (fr) 2022-02-16
JP2021505639A (ja) 2021-02-18

Similar Documents

Publication Publication Date Title
PT3958977T (pt) Derivados de camptotecina
EP3717479C0 (fr) Dérivés de thiazole microbiocides
EP3690038A4 (fr) Conjugué anticorps-dérivé de pyrrolobenzodiazépine
PT3687999T (pt) Derivados de rapamicina
EP3677802A4 (fr) Pièce de glissement
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
EP3457851A4 (fr) Dérivés de sobétirome
MA41898A (fr) Dérivés de quinazolinone bicyclique
EP3654987A4 (fr) Utilisation de dérivés aminoalkylbenzothiazépine
MA54254A (fr) Dérivés de benzodiazépine cytotoxique
MA39822A (fr) Dérivés de pyrimidine bicycle
PT4039675T (pt) Compostos de fenil-2-hidroxi-acetilamino-2-metil-fenilo
EP3283171A4 (fr) Dérivés d'amphotéricine b
PT3625224T (pt) Derivados de indol n-substituídos
EP3430073A4 (fr) Composition de polyaryléthercétone
PL3898637T3 (pl) Pochodne rapamycyny
EP3885347A4 (fr) Dérivé de dihydropyrrolopyrazole
EP3554637A4 (fr) Dérivés de spiropipéridine
PT3796975T (pt) Derivados de sulfonilaminobenzamida
EP3371163A4 (fr) Dérivés de pyrrolidine
EP3383401A4 (fr) Dérivés de thiéno-pyrimidine et utilisations de ceux-ci
MA50068A (fr) Formulations de copanlisib
MA44018A (fr) Dérivés de tétrahydroisoquinoline
PT4056557T (pt) Derivados de benzazepina
MA56504A (fr) Dérivés de pyridin-3-yle